TY - JOUR
T1 - Stat3 activation is limiting for reprogramming to ground state pluripotency
AU - Yang, Jian
AU - Van Oosten, Anouk L.
AU - Theunissen, Thorold W.
AU - Guo, Ge
AU - Silva, Jose C.R.
AU - Smith, Austin
N1 - Funding Information:
We thank Jason Wray for comments on the manuscript and preparation of Gcsf. We are grateful to Jenny Nichols for EpiSCs, Rachel Walker for flow cytometry, Peter Humphreys for imaging, Bill Mansfield for chimera production, and Samuel Jameson and staff for mouse husbandry. Recombinant proteins were provided by Marko Hyvonen. We thank Pierre Savatier for generously providing the Stat3ER T2 construct and Toshio Kitamura for Plat-E cells. This study was supported by the European Commission projects ESTOOLs and EuroSyStem, the Biotechnology and Biological Sciences Research Council, and the Medical Research Council. T.W.T. is a Wellcome Trust PhD Fellow, J.C.R.S. is a Wellcome Trust Career Development Fellow, and A.S. is a Medical Research Council Professor. Author contributions: J.Y. performed and analyzed EpiSC reprogramming experiments, T.W.T. and A.L.v.O. carried out somatic cell reprogramming supervised by J.C.R.S., G.G. provided constructs and advice, and A.S. designed the study and wrote the paper.
PY - 2010/9/3
Y1 - 2010/9/3
N2 - The cytokine leukemia inhibitory factor (Lif) sustains self-renewal of mouse embryonic and induced pluripotent stem cells by activating Jak kinase and the transcription factor Stat3. Here we investigate whether Jak/Stat3 may also contribute to induction of pluripotency. EpiSCs derived from postimplantation embryos express low levels of Lif receptor and Stat3. We introduced into EpiSCs a Jak/Stat3 activating receptor (GY118F) responsive to granulocyte colony stimulating factor (Gcsf). On transfer to ground state culture, in which MAPK signaling and glycogen synthase kinase are inhibited, Gcsf induced transcriptional resetting and functional reprogramming. Activation of a tamoxifen-regulatable fusion, Stat3ERT2, also converted EpiSCs into chimera-competent iPSCs. We exploited GY118F to increase Jak/Stat3 activity during somatic cell reprogramming. Incompletely reprogrammed cells derived from neural stem cells or fibroblasts responded to Gcsf with elevated frequencies of progression to ground state pluripotency. These findings indicate that Jak/Stat3 participate directly in molecular reprogramming and that activation of this pathway is a limiting component.
AB - The cytokine leukemia inhibitory factor (Lif) sustains self-renewal of mouse embryonic and induced pluripotent stem cells by activating Jak kinase and the transcription factor Stat3. Here we investigate whether Jak/Stat3 may also contribute to induction of pluripotency. EpiSCs derived from postimplantation embryos express low levels of Lif receptor and Stat3. We introduced into EpiSCs a Jak/Stat3 activating receptor (GY118F) responsive to granulocyte colony stimulating factor (Gcsf). On transfer to ground state culture, in which MAPK signaling and glycogen synthase kinase are inhibited, Gcsf induced transcriptional resetting and functional reprogramming. Activation of a tamoxifen-regulatable fusion, Stat3ERT2, also converted EpiSCs into chimera-competent iPSCs. We exploited GY118F to increase Jak/Stat3 activity during somatic cell reprogramming. Incompletely reprogrammed cells derived from neural stem cells or fibroblasts responded to Gcsf with elevated frequencies of progression to ground state pluripotency. These findings indicate that Jak/Stat3 participate directly in molecular reprogramming and that activation of this pathway is a limiting component.
UR - http://www.scopus.com/inward/record.url?scp=77956199358&partnerID=8YFLogxK
U2 - 10.1016/j.stem.2010.06.022
DO - 10.1016/j.stem.2010.06.022
M3 - Article
C2 - 20804969
AN - SCOPUS:77956199358
SN - 1934-5909
VL - 7
SP - 319
EP - 328
JO - Cell Stem Cell
JF - Cell Stem Cell
IS - 3
ER -